国际英语新闻:Boeing CEO says China to continue to be U.S. major market, partner
When talking about the significant changes in China, McNerney said, "One of the most important changes in China that I have witnessed - the rapid growth in personal incomes. A growing middle class in China is dramatically reshaping the country' s domestic economy and has global economic impact too."
Regarding Boeing's growing business with China, the CEO exclaimed, "China has bought more than any country in the world (except the U.S.). It has a total of 1,560 airplanes (almost 53 percent of them are Boeing airplanes), and the average age of these planes is just six and a half years - meaning that China also has one of the youngest fleets in the region."
Commenting on the relationship between China and the United States, he noted, "I believe the U.S and China are already interdependent and growing more so every day. In fact, our interdependence with China is key to the U.S. achieving President Obama' s goal of doubling America's exports over the next five years - an increase projected to support two million American jobs at a time when we really need them."
"I expect that the U.S.-China relationship will always be complex, but that global interdependence in business will help keep both nations motivated to work out their differences constructively," he added.
相关文章
- 欧美文化:Emergency rooms see more gun violence victims in U.S. in 1st year of pandemic: CNN
- 欧美文化:Sri Lankan military authorized to maintain law, order amid unrest
- 欧美文化:Russian FM visits Algeria to mark 60th anniversary of ties
- 欧美文化:Turkey, Kazakhstan aim to reach 10 bln USD in bilateral trade: president
- 欧美文化:Macron visits Berlin on first foreign trip after re-election
- 欧美文化:Voting begins in Philippine elections
- 欧美文化:Serbia, China commemorate journalists killed in NATO bombing 23 years ago
- 欧美文化:U.S. unemployment rate unchanged at 3.6 pct in April amid tight labor market
- 欧美文化:Putin, Bennett discuss Ukraine over phone
- 欧美文化:U.S. FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk